Atlas Trials

Early Magnetic Resonance Imaging Response of the Dominant Intraprostatic Lesion After Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer and Correlation With Prostate Specific Antigen Response

Clinical trial NCT06822491 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06822491
Sponsor
University of Zurich
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Prostate CarcinomaLocalized Prostate AdenocarcinomaStereotactic Body RadiotherapyStereotactic RadiotherapyMagnetic Resonance ImagingMultiparametric MRI
Start date
2024-08-20
Primary completion
2026-06-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.